Bookbuilding IPO | ₹13 Cr | Listed at BSE SME | Tue, Sep 23, 2025 - Thu, Sep 25, 2025
| Category | QIB | NII | Retail | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (No. of shares) | 3,52,000 | 5,28,000 | 8,80,000 | 88,000 | 1,78,000 | 2,66,000 | 6,20,000 | 17,66,000 |
| Allotment price (Rs.) | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 |
| No.of applications | 2 | 4 | 6 | 343 | 325 | 668 | 4,872 | 5,546 |
| No.of shares applied | 4,30,000 | 11,46,000 | 15,76,000 | 22,24,000 | 54,54,000 | 76,78,000 | 1,94,88,000 | 2,87,42,000 |
| Amount collected (Rs.cr.) | 3.01 | 8.02 | 11.03 | 15.57 | 38.18 | 53.75 | 136.42 | 201.19 |
| No.of times subscribed | 1.22 | 2.17 | 1.79 | 25.27 | 30.64 | 28.86 | 31.43 | 16.28 |
| No.of shares allotted | 3,52,000 | 5,28,000 | 8,80,000 | 88,000 | 1,78,000 | 2,66,000 | 6,20,000 | 17,66,000 |
| Amount (Rs.cr.) | 2.46 | 3.70 | 6.16 | 0.62 | 1.25 | 1.86 | 4.34 | 12.36 |
| No.of allottees | 2 | 4 | 6 | 14 | 29 | 43 | 155 | 204 |
Aptus Pharma IPO is a public issue of 0.18 Cr equity shares. The issue offers 0.06 Cr shares to retail investors, 0.09 Cr shares to qualified institutional buyers, and 0.03 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 94,000 | 0.66 | 5.05% |
| QIB | 8,80,000 | 6.16 | 47.31% |
| Anchor | 5,28,000 | 3.70 | 28.39% |
| QIB (Ex Anchor) | 3,52,000 | 2.46 | 18.92% |
| NII* | 2,66,000 | 1.86 | 14.30% |
| bNII (> ₹10L) | 1,78,000 | 1.25 | 9.57% |
| sNII (< ₹10L) | 88,000 | 0.62 | 4.73% |
| Retail | 6,20,000 | 4.34 | 33.33% |
| Total | 18,60,000 | 13.02 | 100% |
A total of 5,28,000 shares at a price of Rs 70 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | Sep 22, 2025 |
| Anchor investor price | ₹70.00 |
| Anchor investors as % of QIBs | 60.00% |
| No. of shares locked-in for 30 days | 2,64,000 |
| No. of shares locked-in for 90 days | 2,64,000 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
| S.No. | Anchor Investor | Group Entity | No. of Shares Allotted | Amount (Rs.cr.) | % Allotment within Anchor Investor Portion | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | 31 Degrees North Fund I | 31 DEGREES | 1,92,000 | 1.34 | 36.36 | 10.32 |
| 2 | EMINENCE GLOBAL FUND PCC-EUBILIA CAPITAL PARTNERS FUND I | EMINENCE | 1,92,000 | 1.34 | 36.36 | 10.32 |
| 3 | ZEAL GLOBAL OPPORTUNITIES FUND | ZEAL GLOBAL | 1,44,000 | 1.01 | 27.27 | 7.74 |
| 5,28,000 | 3.70 | 100 | 28.39 |
The Aptus Pharma IPO is subscribed 22.27 times by Sep 25, 2025 17:04.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 1.24 |
| Non Institutional | 28.75 |
| Retail Individual | 31.43 |
| Total Subscription | 22.27 |
An investor can apply in Aptus Pharma IPO online via bank (using ASBA) or the broker (using UPI). The Aptus Pharma IPO shares are offered online only.
The Aptus Pharma IPO is subscribed 22.27 times by Sep 25, 2025 17:04.
The Aptus Pharma IPO allotment status is expected on or around Friday, September 26, 2025. Visit Aptus Pharma IPO allotment status to check.
The Aptus Pharma IPO listing date is September 30, 2025. The equity share of Aptus Pharma IPO will list on BSE SME.
Visit Aptus Pharma IPO subscription status page for real-time bidding information about Aptus Pharma IPO.
| IPO opens On | Tuesday, September 23, 2025 |
| IPO Closes On | Thursday, September 25, 2025 |
| Finalisation of Basis of Allotment | Friday, September 26, 2025 |
| Initiation of Refunds | Monday, September 29, 2025 |
| Credit of Shares to Demat Account | Monday, September 29, 2025 |
| IPO Listing Date | Tuesday, September 30, 2025 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
